Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
100%
Human Papillomavirus Type 16
92%
Carcinogenesis
81%
Malignant Neoplasm
68%
Fluorouracil
63%
Oncoprotein
63%
Precancer
63%
Human Papillomavirus
63%
Infection
57%
Survivin
42%
Abdominal Cancer
39%
STAT3 Protein
36%
Drug Resistance
35%
Curcumin
35%
Hepatitis B Virus
31%
Hepatitis B
31%
Lewis Carcinoma
31%
SARS Coronavirus
31%
Helicobacter Infection
31%
Volasertib
31%
Glutathione Transferase P1
31%
Hedgehog
31%
Chewing Tobacco
31%
Phyllanthus Emblica
31%
Helicobacter Pylori
31%
Seroprevalence
31%
Berberine
31%
Papillomavirus Infection
31%
Gold Nanoparticle
31%
Diseases
27%
Virus DNA
27%
Hepatitis B Antigen
27%
Cyclopamine
26%
Coronavirinae
23%
Hepatitis B(e) Antigen
22%
Small Interfering RNA
19%
Vertical Transmission
18%
Vimentin
15%
Western Blot
14%
Protein E6
14%
Quercetin
13%
Hepatitis B(e) Antibody
13%
Cell Viability
13%
Protein P53
12%
ABCG2
10%
Uvomorulin
10%
Phyllanthus
9%
Protein E7
8%
Ether
7%
Severe Acute Respiratory Syndrome
7%
Medicine and Dentistry
Infection
45%
Precancerous Condition
35%
Volasertib
31%
Helicobacter Pylori
31%
Papillomavirus Infection
31%
Carcinogenesis
31%
Hepatitis B
31%
Cancer Growth
31%
Hepatitis B Virus
31%
Abdominal Cancer
31%
Seroprevalence
31%
Survivin
31%
Hepatitis B Antigen
27%
Virus DNA
27%
Cyclopamine
26%
Human Papillomavirus Type 16
22%
Malignant Neoplasm
22%
Hepatitis B(e) Antigen
22%
Vertical Transmission
18%
Hepatitis B(e) Antibody
13%
SARS Coronavirus
9%
Cervical Cancer Cell Line
9%
Cervical Cancer
9%
Immunoblotting
8%
Immunohistochemistry
8%
Adenocarcinoma
7%
Stomach Adenocarcinoma
7%
Keyphrases
Volasertib
31%
Magnetic Resonance-guided
31%
Radiosensitization
31%
Pig Brain
31%
Lewis Lung Carcinoma
31%
Gold Nanoparticles
31%
Bryophyllum
31%
Phyllanthus Emblica
31%
Indian Gooseberry
31%
Cell Survival
31%
GLI Signaling
25%
Particle Size
19%
CagA
14%
Lewis Lung Carcinoma Cells
12%
DNA Damage
12%
SiHa Cells
12%
Planning Grid
10%
Real-time Magnetic Resonance
10%
Zygoma
10%
Concurrent Monitoring
10%
Baby Born
10%
P. Emblica
9%
Comet Assay
6%
Treatment Group
6%
Clonogenicity
6%
Non-small Cell Lung Cancer (NSCLC)
6%
Gli Inhibitor
6%
Clonogenic Assay
6%
Apoptotic Molecules
6%
Phytochemical Compounds
6%
Crude Leaf Extract
6%
State Populations
6%
Genotoxicity
6%
X-ray Irradiation
6%
Radiosensitizing Effect
6%
HBe Antigen
5%
Commercial Enzymes
5%
Antenatal Women
5%